PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

FDA delay for ph 3 trial approval, page-50

  1. 1,308 Posts.
    lightbulb Created with Sketch. 259
    Yep agreed. Personally I think the time taken by the FDA implies it's not a straight no but that they're deciding on the parameters for the phase 3 trials. Considering how much each patient in the trial costs that's a fairly significant decision from an ongoing cost perspective.
    Surely it has to be very close now, this weekend??
    If the FDA news is favorable and they don't immediately announce a partnership or at least say they are in late stage negotiations with a partner who is analyzing the FDA response then I think they'll wait a couple of days at most for the pump on good news then rattle the tin. If there is a decent pump without an immediate partnership announcement I'm definitely selling some early in the day, as PAR seems to tank late in the session after any decent announcement
    Personal thoughts only
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.000(0.00%)
Mkt cap ! $73.55M
Open High Low Value Volume
21.0¢ 22.0¢ 20.5¢ $222.5K 1.035M

Buyers (Bids)

No. Vol. Price($)
5 77810 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 23000 2
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.